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Abstract
While obesity is an indicated risk factor for hypertensive disorders of pregnancy, smoking
during pregnancy has been shown to be inversely associated with the development of pre-
eclampsia and gestational hypertension. The purpose of this study was to investigate the
combined effects of high body mass index and smoking on hypertensive disorders during
pregnancy. This was a case-control study based on national registers, nested within all
pregnancies in Iceland 1989–2004, resulting in birth at the Landspitali University Hospital.
Cases (n = 500) were matched 1:2 with women without a hypertensive diagnosis who gave
birth in the same year. Body mass index (kg/m2) was based on height and weight at 10–15
weeks of pregnancy. We used logistic regression models to calculate odds ratios and corre-
sponding 95% confidence intervals as measures of association, adjusting for potential con-
founders and tested for additive and multiplicative interactions of body mass index and
smoking. Women’s body mass index during early pregnancy was positively associated with
each hypertensive outcome. Compared with normal weight women, the multivariable
adjusted odds ratio for any hypertensive disorder was 1.8 (95% confidence interval, 1.3–
2.3) for overweight women and 3.1 (95% confidence interval, 2.2–4.3) for obese women.
The odds ratio for any hypertensive disorder with obesity was 3.9 (95% confidence interval
1.8–8.6) among smokers and 3.0 (95% confidence interval 2.1–4.3) among non-smokers.
The effect estimates for hypertensive disorders with high body mass index appeared more
pronounced among smokers than non-smokers, although the observed difference was not
statistically significant. Our findings may help elucidate the complicated interplay of these
lifestyle-related factors with the hypertensive disorders during pregnancy.
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Introduction
Hypertensive disorders, including chronic hypertension, gestational hypertension, and pre-
eclampsia, occur in approximately 6–8% of all pregnancies [1] and are a significant source of
maternal and fetal morbidity [2]. As the prevalence of advanced maternal age [3, 4] and obesity
[5] increase among childbearing women in Western countries, hypertensive disorders are likely
to become increasingly common obstetric conditions. Compared with offspring of normal
pregnancies, offspring of preeclamptic pregnancies have a 1.5-to 2-fold increased risk of peri-
natal or infant mortality. Approximately a third of babies born after a preeclamptic pregnancy
are growth restricted, and preeclampsia is responsible for 15% of all preterm births [6].
While obesity is a known risk factor for preeclampsia and other hypertensive disorders [7,
8], smoking during pregnancy has been shown to be inversely associated with the development
of preeclampsia [9, 10]. Data are scarce on the potential interaction of these two lifestyle-
related factors on these common pregnancy conditions [11]. To what extent maternal smoking
and body mass index (BMI) interact in the development of preeclampsia and gestational hyper-
tension is not well established. We therefore aimed to examine the association between BMI
and hypertensive disorders during pregnancy, accounting for demographic and pregnancy
related factors, as well as to assess the combined effect of BMI and smoking on hypertensive
disorders among pregnant women.
Materials and Methods
Study design
We conducted a case-control study nested within all pregnancies in Iceland 1989–2004, which
resulted in birth at the Landspitali University Hospital. The study was based on data from the
National Medical Birth Registry and maternity records linked via women’s unique personal
identification number.
Health care is publicly funded and accessible to everyone in Iceland. Prenatal care is offered
in a uniform manner at local primary care clinics every two to four weeks of pregnancy (10 vis-
its for nulliparous women and 7 visits for others), with the first prenatal visit occurring between
pregnancy weeks 10 and 15. Women who need specialized care receive more follow up [12].
The Landspitali University Hospital provides secondary and tertiary services for the whole of
Iceland. It covered approximately 2900 births annually, 45000 in total, during the study period
[13, 14], mainly including mothers residing in the capital area (Table 1), as well deliveries
among mothers in need of specialized medical care.
Ascertainment of cases and controls
As cases we randomly selected a total of 500 women from the electronic National Medical
Birth Registry with any registered hypertensive disorder during pregnancy (International Clas-
sification of Disease, 10th Revision [ICD-10] codes, O10-16) [15] and no diagnosis of diabetes
(ICD-10 codes, O24, E08-13). The population was restricted to women without any registered
diagnoses of diabetes in light of evolving clinical guidelines and non-uniform screening of ges-
tational diabetes during the study period [16]. Hypertensive disorders during pregnancy were
further categorized as: pre-existing hypertension (O10), gestational hypertension (O13, O16)
and preeclampsia (O14, O15, O11). Preeclampsia superimposed on pre-existing hypertension
(O11) was included with preeclampsia, as only four such cases were identified. No cases of ges-
tational edema and proteinuria without hypertension (O12) were identified. According to the
diagnostic criteria [17], pre-existing hypertension is defined as hypertension that is present and
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observable before pregnancy or that is diagnosed before the 20th week of pregnancy; gesta-
tional hypertension and preeclampsia occur after pregnancy week 20.
As controls we randomly selected a total of 1000 women from the Medical Birth Registry,
who had no registered diagnosis of a hypertensive disorder or diabetes during pregnancy and
gave birth in the same year as each case (1 case: 2 controls). When selecting the number of
cases and controls we assumed an odds ratio of at least 2.0 for any hypertensive disorder and
80% power.
Measures of body mass index and smoking
Information on measured weight, height and self-reported smoking behavior during pregnancy
was manually retrieved from maternity records. Weight (kg) and height (m) were measured at
Table 1. Demographic and Pregnancy Characteristics of Cases and Controls*.
Total N (%) Cases n (%) Controls n (%) p-value
Total 1445 (100) 483 (100) 962 (100)
Age, years
Mean (SD) 28.4 (± 5.9) 28.1 (± 6.3) 28.5 (± 5.7)
< 25 409 (28.3) 157 (32.5) 252 (26.2) 0.008
25–34 793 (54.9) 238 (49.3) 555 (57.7)
 35 243 (16.8) 88 (18.2) 155 (16.1)
Nationality
Icelandic 1410 (97.6) 469 (97.1) 941 (97.8) 0.45
Other 32 (2.2) 13 (2.7) 19 (2.0)
Missing 3 (0.2) 1 (0.2) 2 (0.2)
Residency
capital area 1087 (75.2) 355 (73.5) 732 (76.1) 0.3
non capital area 257 (17.8) 105 (21.7) 152 (15.8)
Missing 101 (7.0) 23 (4.8) 78 (8.1)
Cohabitation
lives with other parent 1238 (85.7) 412 (85.3) 826 (85.9) 0.81
Single 205 (14.2) 70 (14.5) 135 (14.0)
Missing 2 (0.1) 1 (0.2) 1 (0.1)
Working status
paid work 1046 (72.4) 350 (72.5) 696 (72.3) 0.12
homemaker, not working, disability 28 (1.9) 8 (1.7) 20 (2.1)
student 197 (13.6) 77 (15.9) 120 (12.5)
Other 174 (12.0) 48 (9.9) 126 (13.1)
Parity, n
0 659 (45.6) 285 (59.0) 374 (38.9) <0.0001
1 436 (30.2) 102 (21.1) 334 (34.7)
 2 350 (24.2) 96 (19.9) 254 (26.4)
Multiple gestation
No 1348 (93.3) 437 (90.5) 911 (94.7) 0.004
Yes 97 (6.7) (9.5) 51 (5.3)
Abbreviations: HTD, hypertensive disorder of pregnancy; p-value, Fisher Exact Test for difference in proportions between cases and controls, SD,
standard deviation.
* Cases and controls gave birth in the same calendar year. All cases and controls are restricted to women without any registered diabetes during
pregnancy.
doi:10.1371/journal.pone.0152187.t001
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the first prenatal visit, which occurred on average at pregnancy week 13.2 (median, 13.8 weeks;
interquartile range, 12.0–15.3 weeks) in the study population. Body mass index (BMI) was
defined in accordance with international standards [18] as kg/m2 and used as a continuous and
a categorical variable: underweight (BMI< 18.5), normal weight (BMI 18.5–24.9), overweight
(BMI 25.0–29.9), obese (BMI 30.0). BMI was available for 1445 (96.3%) of the study popula-
tion, i.e. 483 (96.4%) of cases and 962 (96.3%) of controls.
Smoking behavior was self-reported at first prenatal visit and categorized as: non-smoker,
smoker and discontinued smoker (smoked during early pregnancy but quit). Of the 1445
women with known BMI, 77.8% (n = 1124) reported no smoking, 17.9% (n = 259) reported
smoking during pregnancy, another 2.8% (n = 41) discontinued smoking during pregnancy,
and 1.5% (n = 21) had an unknown smoking status. In the analyses we excluded discontinued
smokers because of uncertainty of when exactly smoking had been discontinued. Information
on quantity or type of smoking was not available.
Covariates
Additionally, we obtained information on women’s demographic and pregnancy related char-
acteristics from the National Medical Birth Registry, including maternal age at delivery, nation-
ality, residency, working status and cohabitation with other parent, parity, multiple gestation
and gestational length. Other registered maternal conditions, such as renal diseases (ICD-10
codes N00-N99, Q61, O27.1), collagen vascular diseases (ICD-10 codes L93, L94) and endo-
crine disorders (ICD-10 codes E00-E90) were assessed but not used as covariates because of
too few observations.
Data analysis
Of 1500 unique personal identification numbers extracted, records were incomplete or unavail-
able for three women and data on BMI missing for another 52 women; resulting in 1445
women (483 cases, 962 controls) available for the main data analysis. Analyses in which smok-
ing status was included contained a total of 1383 women after exclusion of those with missing
values (n = 21) and discontinued smoking (n = 41).
We first calculated the crude odds, odds ratios (OR) and corresponding 95% confidence
intervals (CI), as measures of association of hypertensive disorders during pregnancies (any;
pre-existing hypertension, gestational hypertension, preeclampsia) separately with BMI groups
(normal weight, overweight, obese) and smoking status (no, yes). With logistic regression mod-
els we then simultaneously adjusted for all relevant covariates (maternal age at delivery, parity
and multiple gestations) identified by backward selection and Yates continuity corrections
[19]. Other available covariates did not affect the effect estimates, but in all instances calendar
year was controlled for by the study design, i.e. matching on year of birth. As the matching cri-
teria was wide, i.e. the only matching condition being that cases and controls gave birth during
the same calendar year, we chose not to conduct conditional regression models. We tested
additive and multiplicative interactions of maternal smoking and overweight/obesity and esti-
mated multiplicative joint effects for maternal smoking and overweight/obesity.
We performed sensitivity analyses: 1) To validate the registration of hypertensive outcomes
in the Medical Birth Registry we extracted systolic (SBP) and diastolic blood pressure (DBP)
levels, measured at first and last prenatal visits, from the maternity records of all cases and con-
trols. S1 Fig demonstrates higher blood pressure values among cases than controls, especially at
the last prenatal visit. (S1 Fig. Mean Blood Pressure (mmHg) by Diagnosis of Hypertensive
Disorder during Pregnancy). We then further restricted hypertensive cases to those that met
the threshold of at least 140 mmHg SBP or 90 mmHg DBP at the last (preeclampsia, gestational
BMI, Smoking and Hypertensive Disorders during Pregnancy
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hypertension) and first prenatal visit (pre-existing hypertension). Data on proteinuria in
maternity records were not accessible to use for validation of the hypertensive outcomes. 2) To
evaluate the effect of potential misclassification of BMI exposure because of weight gained in
early pregnancy, we restricted all analyses to women who had their first prenatal visit before
the end of pregnancy week 15.
All analyses were performed using R.2.7 (R Foundation for Statistical Computing,
Vienna, Austria) statistical software for computing. The study was approved by the Icelan-
dic National Bioethics Committee (VSNb2012040011/03.07) and the Data Protection
Authority (2012050619AT/-). An informed consent from women in the study population
was not obtained as all personal information was anonymized and de-identified prior to
analysis.
Results
Demographic and pregnancy characteristics of women with hypertensive disorders during
pregnancy (cases) and controls (no hypertensive disorders) are detailed in Table 1.
The demographic characteristics of cases and controls were largely similar, but they differed
in parity. Hypertensive cases were more likely than controls to be nulliparous (59% vs. 39%),
and they were also slightly younger than the controls (28.1 vs. 28.5 years). The distribution of
characteristics of women with known and unknown BMI values were also similar (S1 Table),
except women with missing BMI were more likely to be non-Icelandic.
According to measured height and weight at around 13 weeks of pregnancy, 1.7% (n = 24)
of the 1445 women were underweight, 57.4% (n = 829) were normal weight, 26.0% (n = 376)
overweight and 14.9% (n = 216) were obese. We collapsed the underweight women with the
normal weight group in all analyses.
The odds of being diagnosed with a hypertensive disorder during pregnancy were lower for
smokers than non-smokers (13.9% vs. 21.2%); with a crude odds ratio of 0.60 (95% CI 0.44–
0.82). Adjusting for parity, multiple gestation, maternal age or any other available covariate did
not affect the effect estimate (ORadjusted = 0.60, 95% CI 0.44–0.82). We found a reverse associa-
tion of smoking with each separate hypertensive outcome but the OR magnitude differed; pre-
eclampsia (ORadjusted = 0.68, 95% CI 0.47–0.96), gestational hypertension (ORadjusted = 0.31,
95% CI 0.13–0.75) and pre-existing hypertension (ORadjusted = 0.53, 95% CI 0.26–0.97). The
point estimates of the reverse associations diminished in magnitude with increasing BMI, for
any hypertensive disorder and for preeclampsia as shown in S2 Table.
The associations between BMI and hypertensive disorder during pregnancy are detailed in
Table 2.
Compared with normal weight women, both overweight and obese women had higher odds
of any hypertensive disorders during pregnancy. The crude odds ratio for any hypertensive dis-
order was 1.63 (95% Cl 1.26–2.11) for overweight women and 2.79 (95% Cl 2.05–3.80) for
obese women. Adjusting for parity, multiple gestation and maternal age amplified positive
effect estimates somewhat. We found positive associations of BMI with each separate hyperten-
sive outcome (preeclampsia, gestational hypertension and pre-existing hypertension). In com-
parison to normal weight women, the odds of preeclampsia and gestational hypertension
increased by about 1.7-fold for overweight women and 2.4- to 3-fold for obese women, with
effect estimates slightly higher when adjusting for parity, multiple gestation and maternal age.
The adjusted odds ratios were highest for pre-existing hypertension; 1.79 and 4.42 among over-
weight and obese women, respectively, compared with normal weight women. Only maternal
age seemed to affect the association between BMI and pre-existing hypertension, by slightly
attenuating the estimates.
BMI, Smoking and Hypertensive Disorders during Pregnancy
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Table 3 demonstrates the estimated joint effect of overweight/obesity and smoking on
hypertensive disorders during pregnancy.
The odds ratio for any hypertensive disorder was 3.91 (95% Cl 1.78–8.59) among smokers
and 2.98 (95% Cl 2.07–4.31) among non-smokers, when comparing obese with normal weight
women. The effect estimates stratified by smoking status were of similar magnitude for pre-
eclampsia, but we lacked statistical power to meaningfully evaluate the association of BMI with
gestational hypertension and pre-existing hypertension. Neither additive nor multiplicative
interactions of maternal smoking and overweight/obesity were significant. We found a signifi-
cant joint effect in a multiplicative scale for maternal smoking and obesity for any hypertension
(p-value = 0.025), preexisting hypertension (p-value<0.001) but not for preeclampsia (p-
value = 0.077).
Analyzing BMI as a continuous independent variable did not significantly alter the results
of the main analysis associations demonstrated in Tables 2 and 3. Restricting all analyses to
women with the first prenatal visit before end of pregnancy week 15 did not significantly alter
the observed effect estimates. Restricting cases to women with the specified blood pressure cri-
teria led to increased OR magnitudes for the associations of BMI with preeclampsia and gesta-
tional hypertension, but attenuated OR magnitudes for pre-existing hypertension (data not
shown).
Discussion
The results of this population based case-control study indicate that overweight and obese
women are, compared with women of normal weight, at increased risk of hypertensive disor-
ders during pregnancy, including preeclampsia and gestational hypertension. In our data the
risk increased appeared to be amplified in women who smoke. Conversely, smoking alone
Table 2. Association of Body Mass Index with Hypertensive Disorders during Pregnancy.
Total N Cases n
(%)
Controls n (%) Crude OR (95% Cl) Adjusted OR* (95% Cl)
Any HTD 1445 483 (100) 962 (100)
normal weight (BMI <24.9) 853 231 (47.8) 622 (64.7) 1.0 1.0
overweight (BMI 25–29.9) 376 142 (29.4) 234 (24.3) 1.63 (1.26–2.11) 1.75 (1.34–2.29)
obese (BMI 30) 216 110 (22.8) 106 (11.0) 2.79 (2.05–3.80) 3.08 (2.24–4.25)
Preeclampsia 1275 313 962
normal weight (BMI <24.9) 783 161 (51.4) 622 (64.7) 1.0 1.0
overweight (BMI 25–29.9) 327 93 (29.7) 234 (24.3) 1.54 (1.14–2.06) 1.72 (1.26–2.34)
obese (BMI 30) 165 59 (18.9) 106 (11.0) 2.15 (1.49–3.08) 2.37 (1.62–3.46)
Gestational hypertension 1037 75 962
normal weight (BMI <24.9) 657 35 (46.7) 625 (64.7) 1.0 1.0
overweight (BMI 25–29.9) 257 23 (30.7) 234 (24.3) 1.75 (1.00–3.01) 1.77 (1.00–3.09)
obese (BMI 30) 123 17 (22.7) 106 (11.0) 2.86 (1.51–5.23) 2.96 (1.55–5.47)
Pre-existing hypertension 1057 95 962
normal weight (BMI <24.9) 657 35 (36.8) 622 (64.7) 1.0 1.0
overweight (BMI 25–29.9) 260 26 (27.4) 234 (24.3) 1.98 (1.15–3.35) 1.79 (1.04–3.06)
obese (BMI 30) 140 34 (35.8) 106 (11.0) 5.68 (3.38–9.55) 4.42 (3.20–9.21)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; HTD, hypertensive disorder of pregnancy; OR, odds ratio.
* Adjusted for parity, multiple gestation and maternal age. Cases and controls gave birth in the same calendar year. All cases and controls are restricted
to women without any registered diabetes during pregnancy.
doi:10.1371/journal.pone.0152187.t002
BMI, Smoking and Hypertensive Disorders during Pregnancy
PLOS ONE | DOI:10.1371/journal.pone.0152187 March 24, 2016 6 / 12
appears to attenuate the risk of hypertensive disorders during pregnancy. These findings may
help elucidate the complicated interplay of these lifestyle-related factors with the hypertensive
disorders.
The risk increase we observed for hypertensive disorders during pregnancy was nearly
2-fold among overweight women and 3-fold among obese women when compared with nor-
mal weight women. A dose-dependent relation of BMI was apparent with each separate hyper-
tensive outcome, i.e. preeclampsia, pre-existing and gestational hypertension. This is consistent
with previous results found among pregnant women, although most have focused on the rela-
tionship with preeclampsia [20, 21]. But as Bateman et al. [22] demonstrated, using nationally
representative data from NHANES, obesity is an independent risk factor for hypertension
among all women of reproductive age, with prevalence increasing in near linear fashion with
BMI.
Consistent with the elevated risk for preeclampsia observed among overweight (OR =
1.7) and obese (OR = 2.4) women in our data, Bodnar et al. [20] also found that pre-preg-
nancy BMI had a dose-dependent relation with preeclampsia, with a triple risk among
women with a BMI of 30 compared with women who had a BMI of 21. These findings are in
Table 3. Association of Body Mass Index with Hypertensive Disorders during Pregnancy Stratified by Smoking Status.
Non-smokers Smokers
Total
N
Cases n
(%)
Controls n
(%)
Adjusted OR* (95%
Cl)
Total
N
Cases n
(%)
Controls n
(%)
Adjusted OR* (95%
Cl)
Any HTD 1124 402 (100) 722 (100) 259 65 (100) 194 (100)
Normal weight (BMI
<24.9)
669 199 (49.5) 470 (65.1) 1.0 148 26 (40.0) 122 (62.9) 1.0
Overweight (BMI25-
29.9)
289 116 (28.9) 173 (24.0) 1.78 (1.31–2.42) 73 22 (33.8) 51 (26.3) 2.04 (1.05–3.96)
Obese (BMI >30) 166 87 (21.6) 79 (10.9) 2.98 (2.07–4.31) 38 17 (26.2) 21 (10.8) 3.91 (1.78–8.59)
Preeclampsia 975 253 722 242 48 194
Normal weight (BMI
<24.9)
607 137 (54.2) 470 (65.1) 1.0 141 19 (39.6) 122 (62.9) 1.0
Overweight (BMI25-
29.9)
245 72 (28.5) 173 (24.0) 1.68 (1.18–2.40) 69 18 (37.5) 51 (26.3) 2.29 (1.09–4.79)
Obese (BMI >30) 123 44 (17.3) 79 (10.9) 2.19 (1.41–3.41) 32 11 (22.9) 21 (10.8) 3.41 (1.38–8.45)
Gestational
hypertension
789 67 722 200 6 194
Normal weight (BMI
<24.9)
503 33 (49.3) 470 (65.1) 1.0 124 2 (33.3) 122 (62.9) 1.0
Overweight (BMI25-
29.9)
193 20 (29.9) 173 (24.0) 1.75 (0.96–3.21) 54 3 (50) 51 (26.3) 3.74 (0.58–23.91)
Obese (BMI >30) 93 14 (20.9) 79 (10.9) 2.73 (1.37–5.46) 22 1 (16.7) 21 (10.8) 3.18 (0.26–38.44)
Pre-existing
hypertension
804 82 722 205 11 194
Normal weight (BMI
<24.9)
499 29 (35.4) 470 (65.1) 1.0 127 5 (45.5) 122 (62.9) 1.0
Overweight (BMI25-
29.9)
197 24 (29.2) 173 (24.0) 1.99 (1.11–3.58) 52 1 (9) 51 (26.3) 0.52 (0.06–4.64)
Obese (BMI >30) 108 29 (35.4) 79 (10.9) 5.87 (3.37–10.56) 26 5 (45.5) 21 (10.8) 6.28 (1.62–24.41)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; HTD, hypertensive disorder of pregnancy; OR, odds ratio.
* Adjusted for parity, multiple gestation and maternal age. Cases and controls gave birth in the same calendar year. All cases and controls are restricted
to women without any registered diabetes during pregnancy.
doi:10.1371/journal.pone.0152187.t003
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line with the results of a systematic review from 2003, including 13 cohort studies, that the
risk of developing preeclampsia doubled for every 5–7 kg/m2 increase in BMI [23]. Most
previous studies assessing BMI and gestational hypertension have analyzed it as a combined
outcome with preeclampsia [20, 24]. As these two hypertensive conditions have been shown
to share many risk factors [25], their similar association with BMI as demonstrated in our
data is not of surprise.
Pre-existing hypertension and preeclampsia/gestational hypertension are, on the other
hand, viewed as independent entities [17]. While the latter generally occur after week 20 of
pregnancy, pre-existing hypertension is by definition detected earlier. Several studies have,
however, demonstrated these different entities to share at least one risk factor, namely obe-
sity [22, 26]. But as BMI and smoking-status were measured after the onset of pre-existing
hypertension in our data, we cannot ascertain these as definite causal risk factors for pre-
existing hypertension, even though effect estimates indicate associations thereof. Advanced
age has also been considered in previous studies a risk factor for pre-existing hypertension
[22]. After adjusting for age in our data the positive relationship between overweight/obe-
sity and pre-existing hypertension remained, although slightly attenuated, which could
reflect an independent effects of age or the duration of obesity or smoking habits on the
outcome.
In line with previous findings [27–29], our data showed an inverse association between
smoking and preeclampsia/gestational hypertension, primarily in women of normal weight.
Conclusive results regarding potential effect modification of BMI on this association between
smoking and hypertensive disorders can, however, not be drawn from our data due to lack of
statistical power. Although non-conclusive, underlying biologic pathways for this inverse asso-
ciation have been hypothesized; such as the role of circulating angiogenic proteins [30], which
could be released through the combustion of tobacco products, e.g. carbon monoxide [29].
Recently it has also been hypothesized that this inverse association with smoking may be due
to miscarriage, or preterm delivery, of pregnancies with poor placentation due to smoking, i.e.
smokers that would have developed hypertension or preeclampsia had they completed 40
weeks [31, 32]. In our data, cases, i.e. women with hypertensive disorders, were more likely
than controls to give births preterm.
But how does smoking affect the observed risk increase among overweight and obese
women for hypertensive disorders? Although our results indicated that the increased risk of
hypertensive disorders with overweight/obesity might be higher among smokers than non-
smokers, observations based on a larger number of pregnancies are needed to draw a definite
conclusion on this. Previous studies have shown somewhat conflicting results on the com-
bined association of BMI and smoking on the hypertensive outcomes during pregnancy.
While, very few studies have examined smoking as an effect modifier, some have studied
how BMI affects the association between smoking and hypertensive disorders. Stone et al.
[33] suggested in a retrospective study based on data from birth certificates, that smoking
decreased the risk for preeclampsia regardless of women pre-pregnancy BMI. While on the
other hand, Ness et al. [11] showed in a large, prospective cohort study that the inverse asso-
ciation between preeclampsia and smoking was eliminated if a woman was overweight or
obese. However, as their study data were based on 7,757 pregnancies from over five decades
ago, i.e. 1959 to 1965, obese and overweight women had to be pooled into one group for the
lack of obese women. Nevertheless, the results of Ness et al. are in line with our supplemen-
tary data indicating that the inverse association decreases as women’s BMI increases,
although lack of statistical power in our data impedes conclusive results on smoking as an
effect modifier.
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Study strengths and limitations
The present study was conducted over a 15-year period in Iceland, where women have equal
access to prenatal care free of charge [12]. The data originated from women who gave birth at
the National University Hospital, where over 75% of all births in the country occurred [13].
The study strengths mainly lie in the homogeneous study population, uniform diagnostic- and
health care system, which reduce residual confounding by factors such as socio-economic sta-
tus and differential prenatal care. Although the biological effects studied are likely to be gener-
alizable beyond the Icelandic population, this cannot be empirically validated and, as such, the
homogeneity may compromise the generalizability of our findings.
Our study has several limitations. First, we restricted the study population to women
with no registered diagnosis of diabetes, as screening was not uniform during the study
period. Future work will need to be directed at understanding the role of diabetes as a con-
founder/mediator of the association between BMI and hypertensive disorders, and the way
in which it impacts on the observed interaction between BMI, smoking status, and hyperten-
sive disorders. Second, the exact dates of hypertensive diagnoses were not available, limiting
our possibility to know if the disorder had an early or late onset (i.e. before or after week 34
of pregnancy). Previous findings have indicated that while early onset of preeclampsia may
be linked to abnormal placentation [34] and have a genetic component [35], late onset is
more likely to be related to maternal factors [34, 36]. In both instances, though, obesity has
been indicated as a crucial risk factor [21]. Third, although all hypertensive diagnoses in this
study were based on ICD-10 codes, misclassification of disease status may be a possibility
and our data do not include information on patients’ history or family history of hyperten-
sion during pregnancy. To evaluate the validity of diagnoses in the Medical Birth Registry
we compared women’s diagnosis status with their mean blood pressure values, as registered
in maternity records at the first and last prenatal visits. When we restricted cases to women
who additionally met the blood pressure criteria for hypertension according to maternity
records, the effect estimates were intensified for both preeclampsia and gestational hyper-
tension. Fourth, misclassification of exposure is also a possibility. To minimize the effect
misclassification due to weight gained during early pregnancy, we restricted all analyses to
women who had their BMI measured before the end of pregnancy week 15 and found very
similar effect estimates as observed in the main analyses. Further, demographic and preg-
nancy characteristics were similarly distributed between women with known and unknown
BMI. Finally, as smoking was self-reported some women may have misreported their status.
We would expect such misreporting mainly to have been smokers classified as non-smokers,
which would in turn have attenuated the observed difference in effect estimates for hyper-
tensive disorders with overweight/obesity between smokers and non-smokers. Similarly,
such misreporting would have attenuated the inverse associations found between smoking
and hypertensive disorders.
Conclusion
In conclusion, our data indicate that obesity and overweight play a crucial role in relation to
hypertensive disorders during pregnancy and that smoking may potentially magnify this rela-
tion even further. Further research is needed to draw definite conclusions about the combined
effects of these lifestyle-related factors on the hypertensive disorders, especially in light of cur-
rent and previous findings showing that smoking has an independent inverse association with
hypertensive disorders during pregnancy.
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